EUVIMEDEUVIMED entdecken
Crossref

Targeting FAK‐YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis

Hao Zhou, Yu-Zhang Wang, Shi-Man Zhang iD, Xiao Yan, Hong Chen, Sheng-Xin Jin, Wei-Hai Chen iD, Xian-Zheng Zhang iD

Advanced Materials · 2026-11 · 38 (63)

DOI: 10.1002/adma.75155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 26.09.2026. Verfasst von Hao Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital & Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan Univers…. Hauptthemen laut MEDLINE: Cuproptosis, Signal Transduction, Neoplastic Stem Cells, Focal Adhesion Kinase 1. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hubei Province Science and Technology Innovation Talent Program, Institutional Animal Care and Use Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis has recently been identified as a novel metabolic cell death pathway that holds great promise for cancer therapy. However, cuproptosis resistance developed by tumor cells severely impairs its anticancer efficacy. Here, our study uncovers that the FAK‐YAP signaling axis in tumor cells plays important roles in the development of cuproptosis resistance and the promotion of tumor stemness. To therapeutically target this signaling axis, a CRISPR‐cuproptosis synergistic nanoplatform (CPLNP@HA) is elaborately designed for targeted co‐delivery of a Ptk2 (encoding FAK) CRISPR‐Cas9 knockout plasmid to block FAK‐YAP signaling axis and Cu‐elesclomol (Cu‐ES, a cuproptosis inducer) into tumor cells. Mechanistically, CPLNP@HA efficiently silences FAK expression, which subsequently blocks the cuproptosis‐induced activation of the FAK‐YAP signaling cascade. This intervention not only sustains intracellular copper accumulation to reinforce cuproptosis but also reduces tumor stemness, thereby significantly potentiating the therapeutic outcomes of cuproptosis and activating tumoricidal immunity as evidenced by transcriptomic analysis. In combination with immune checkpoint blockade therapy, CPLNP@HA markedly inhibits tumor development upon rechallenge after surgical resection. Our work establishes FAK‐YAP signaling axis as a new therapeutic target to overcome cuproptosis resistance and inhibit tumor stemness, providing a promising combinatorial paradigm to sensitize tumor to cuproptosis and immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuproptosisSignal TransductionNeoplastic Stem CellsFocal Adhesion Kinase 1Transcription FactorsAdaptor Proteins, Signal TransducingHumansCell Line, TumorYAP-Signaling ProteinsAnimalsDrug Resistance, NeoplasmCRISPR-Cas Systems

Stichwörter der Autor:innen

CRISPR‐Cas9FAK‐YAP signalingcuproptosis resistancetumor stemnesstumor therapy

Substanzen

YAP-Signaling ProteinsFocal Adhesion Kinase 1YAP1 protein, humanTranscription FactorsAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Cardiology, Zhongnan Hospital & Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, P. R. China.

ORCID-Profile: Shi-Man Zhang, Wei-Hai Chen, Xian-Zheng Zhang

Förderung

  • National Natural Science Foundation of China
  • Hubei Province Science and Technology Innovation Talent Program
  • Institutional Animal Care and Use Committee
  • Animal Experiment Center of Wuhan University

Zitieren

APA

Zhou, H., Wang, Y. Z., Zhang, S. M., Yan, X., Chen, H., Jin, S. X., Chen, W. H., & Zhang, X. Z. (2026). Targeting FAK‐YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis. Advanced Materials, 38(63). https://doi.org/10.1002/adma.75155

Vancouver

Zhou H, Wang YZ, Zhang SM, Yan X, Chen H, Jin SX, et al. Targeting FAK‐YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis. Advanced Materials. 2026;38(63). doi:10.1002/adma.75155

BibTeX
@article{Zhou2026,
  author = {Zhou, Hao and Wang, Yu-Zhang and Zhang, Shi-Man and Yan, Xiao and Chen, Hong and Jin, Sheng-Xin and Chen, Wei-Hai and Zhang, Xian-Zheng},
  title = {Targeting FAK‐YAP Signaling Axis Inhibits Tumor Stemness and Overcomes Tumor Resistance to Cuproptosis},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {63},
  doi = {10.1002/adma.75155}
}
Kostenlos starten →